•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer
Warrior Met Coal Inc (HCC) Shares Fall 4.3% -- What GF Score of 81 Tells Investors
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
This $4 Million Warrior Met Coal Sale May Be More About Profit Taking Than Coal Prices
Warrior Met Coal, Inc. (HCC) Q1 2026 Earnings Call Transcript
Warrior Met Coal (HCC) Tops Q1 Earnings and Revenue Estimates
Warrior Reports First Quarter 2026 Results
Warrior Announces Regular Quarterly Cash Dividend
Warrior Met Coal $HCC Shares Purchased by Moran Wealth Management LLC
Warrior Met Coal: A Low-Cost Premium Coking Coal Producer
Warrior Sets Date for First Quarter 2026 Earnings Announcement and Investor Conference Call
3 Coal Stocks to Avoid as the Industry Battles Multiple Challenges
Warrior Met Coal (NYSE:HCC) Receives Consensus Rating of “Hold” from Brokerages
Warrior Met Coal $HCC Shares Acquired by Capital International Investors
American Century Companies Inc. Lowers Position in Warrior Met Coal $HCC
Warrior Publishes 2025 Corporate Responsibility Report
BTC Capital Management Inc. Purchases 10,733 Shares of Warrior Met Coal $HCC
Mohnish Pabrai's Strategic Moves: Valaris Ltd Sees a Significant Reduction of -8.79%